240 related articles for article (PubMed ID: 38012307)
1. Genetically encoding multiple functionalities into extracellular vesicles for the targeted delivery of biologics to T cells.
Stranford DM; Simons LM; Berman KE; Cheng L; DiBiase BN; Hung ME; Lucks JB; Hultquist JF; Leonard JN
Nat Biomed Eng; 2024 Apr; 8(4):397-414. PubMed ID: 38012307
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered loaded extracellular vesicles for drug delivery.
Erana-Perez Z; Igartua M; Santos-Vizcaino E; Hernandez RM
Trends Pharmacol Sci; 2024 Apr; 45(4):350-365. PubMed ID: 38508958
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification.
Liu Q; Li D; Pan X; Liang Y
J Nanobiotechnology; 2023 Sep; 21(1):334. PubMed ID: 37717008
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin-kexin type 9 (Pcsk9) in primary mouse hepatocytes.
Ilahibaks NF; Kluiver TA; de Jong OG; de Jager SCA; Schiffelers RM; Vader P; Peng WC; Lei Z; Sluijter JPG
J Extracell Vesicles; 2024 Jan; 13(1):e12389. PubMed ID: 38191764
[TBL] [Abstract][Full Text] [Related]
5. Engineered extracellular vesicles expressing ICAM-1: A promising targeted delivery system for T cell modifications.
Farahani MS; Hosseini-Beheshti E; Moazzeni SM; Moghadam MF
Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130541. PubMed ID: 38103755
[TBL] [Abstract][Full Text] [Related]
6. Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing.
Whitley JA; Cai H
J Extracell Vesicles; 2023 Sep; 12(9):e12343. PubMed ID: 37723839
[TBL] [Abstract][Full Text] [Related]
7. Creating Designer Engineered Extracellular Vesicles for Diverse Ligand Display, Target Recognition, and Controlled Protein Loading and Delivery.
Ivanova A; Badertscher L; O'Driscoll G; Bergman J; Gordon E; Gunnarsson A; Johansson C; Munson MJ; Spinelli C; Torstensson S; Vilén L; Voirel A; Wiseman J; Rak J; Dekker N; Lázaro-Ibáñez E
Adv Sci (Weinh); 2023 Dec; 10(34):e2304389. PubMed ID: 37867228
[TBL] [Abstract][Full Text] [Related]
8. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
9. Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer.
Wang Y; Chen X; Tian B; Liu J; Yang L; Zeng L; Chen T; Hong A; Wang X
Theranostics; 2017; 7(5):1360-1372. PubMed ID: 28435471
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming Extracellular Vesicles for Protein Therapeutics Delivery.
Ovchinnikova LA; Terekhov SS; Ziganshin RH; Bagrov DV; Filimonova IN; Zalevsky AO; Lomakin YA
Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34064144
[TBL] [Abstract][Full Text] [Related]
11. Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug delivery.
Meng W; Wang L; Du X; Xie M; Yang F; Li F; Wu ZE; Gan J; Wei H; Cao C; Lu S; Cao B; Li L; Li L; Zhu G
J Control Release; 2023 Nov; 363():235-252. PubMed ID: 37739016
[TBL] [Abstract][Full Text] [Related]
12. Thinking Quantitatively of RNA-Based Information Transfer via Extracellular Vesicles: Lessons to Learn for the Design of RNA-Loaded EVs.
Piffoux M; Volatron J; Silva AKA; Gazeau F
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834346
[TBL] [Abstract][Full Text] [Related]
13. Engineering Extracellular Vesicles to Target Pancreatic Tissue
Komuro H; Kawai-Harada Y; Aminova S; Pascual N; Malik A; Contag CH; Harada M
Nanotheranostics; 2021; 5(4):378-390. PubMed ID: 33912378
[TBL] [Abstract][Full Text] [Related]
14. A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery.
Hung ME; Leonard JN
J Extracell Vesicles; 2016; 5():31027. PubMed ID: 27189348
[TBL] [Abstract][Full Text] [Related]
15. Emerging technologies for engineering of extracellular vesicles.
Zhou X; Huang Q; Jiang Y; Tang H; Zhang L; Li D; Xu Y
Front Bioeng Biotechnol; 2023; 11():1298746. PubMed ID: 38026881
[TBL] [Abstract][Full Text] [Related]
16. Real-Time Luminescence Assay for Cytoplasmic Cargo Delivery of Extracellular Vesicles.
Somiya M; Kuroda S
Anal Chem; 2021 Apr; 93(13):5612-5620. PubMed ID: 33759512
[TBL] [Abstract][Full Text] [Related]
17. Fusogenic Hybrid Extracellular Vesicles with PD-1 Membrane Proteins for the Cytosolic Delivery of Cargos.
Ishikawa R; Yoshida S; Sawada SI; Sasaki Y; Akiyoshi K
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681615
[TBL] [Abstract][Full Text] [Related]
18. Encapsulating Cas9 into extracellular vesicles by protein myristoylation.
Whitley JA; Kim S; Lou L; Ye C; Alsaidan OA; Sulejmani E; Cai J; Desrochers EG; Beharry Z; Rickman CB; Klingeborn M; Liu Y; Xie ZR; Cai H
J Extracell Vesicles; 2022 Apr; 11(4):e12196. PubMed ID: 35384352
[TBL] [Abstract][Full Text] [Related]
19. Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing.
Yao X; Lyu P; Yoo K; Yadav MK; Singh R; Atala A; Lu B
J Extracell Vesicles; 2021 Mar; 10(5):e12076. PubMed ID: 33747370
[TBL] [Abstract][Full Text] [Related]
20. Engineering extracellular vesicles as novel treatment options: exploiting herpesviral immunity in CLL.
Gärtner K; Luckner M; Wanner G; Zeidler R
J Extracell Vesicles; 2019; 8(1):1573051. PubMed ID: 30788083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
